GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform

Jack Brydon, Radovan Krejcir, Filip Zavadil-Kokas, Ashita Singh, Tomas Henek, Lenka Hernychova, Skye Coleman, Sofian Al Shboul, Vaclav Hrabal, Zuzana Kuncova, Marcos Yébenes Mayordomo, Łukasz Arcimowicz, Kathryn L. Ball, Monikaben Padariya, Umesh Kalathiya, Borivoj Vojtesek, Ted Hupp, J. R. O’Neill

Open source

DOI: 10.1186/s11658-025-00852-1
Published: 2026-03-10
Container: Cellular & Molecular Biology Letters
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s11658-025-00852-1,
  title = {GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform},
  author = {Jack Brydon and Radovan Krejcir and Filip Zavadil-Kokas and Ashita Singh and Tomas Henek and Lenka Hernychova and Skye Coleman and Sofian Al Shboul and Vaclav Hrabal and Zuzana Kuncova and Marcos Yébenes Mayordomo and Łukasz Arcimowicz and Kathryn L. Ball and Monikaben Padariya and Umesh Kalathiya and Borivoj Vojtesek and Ted Hupp and J. R. O’Neill},
  year = {2026},
  journal = {Cellular \&amp; Molecular Biology Letters},
  doi = {10.1186/s11658-025-00852-1},
  url = {https://doi.org/10.1186/s11658-025-00852-1}
}

RIS

TY  - JOUR
TI  - GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform
AU  - Jack Brydon
AU  - Radovan Krejcir
AU  - Filip Zavadil-Kokas
AU  - Ashita Singh
AU  - Tomas Henek
AU  - Lenka Hernychova
AU  - Skye Coleman
AU  - Sofian Al Shboul
AU  - Vaclav Hrabal
AU  - Zuzana Kuncova
AU  - Marcos Yébenes Mayordomo
AU  - Łukasz Arcimowicz
AU  - Kathryn L. Ball
AU  - Monikaben Padariya
AU  - Umesh Kalathiya
AU  - Borivoj Vojtesek
AU  - Ted Hupp
AU  - J. R. O’Neill
PY  - 2026
JO  - Cellular &amp; Molecular Biology Letters
DO  - 10.1186/s11658-025-00852-1
UR  - https://doi.org/10.1186/s11658-025-00852-1
ER  -

APA

Brydon, J., Krejcir, R., Zavadil-Kokas, F., Singh, A., Henek, T., Hernychova, L., Coleman, S., Shboul, S. A., Hrabal, V., Kuncova, Z., Mayordomo, M. Y., Arcimowicz, Ł., Ball, K. L., Padariya, M., Kalathiya, U., Vojtesek, B., Hupp, T., & O’Neill, J. R. (2026). GPA33 forms a distinct diagnostic target class to Claudin 18.2 in oesophageal adenocarcinoma enabling the development of a novel GPA33 antibody-based detection platform. Cellular & Molecular Biology Letters. https://doi.org/10.1186/s11658-025-00852-1

Source records

crossref · retrieved 2026-11-10T14:09:18.079Z